Treatment with recombinant human PDGF-BB increased Mcl-1 mRNA in a dose- and time-dependent manner, though the optimal conditions for the maximum accumulation of Mcl-1 mRNA varied in different PCa cell lines. Here, MCL1 is linked to posterior cortical atrophy.